AEON
$1.16
Post-MarketAs of Mar 17, 8:00 PM UTC
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
An Intrinsic Calculation For Aeon Co. (M) Bhd. (KLSE:AEON) Suggests It's 42% Undervalued
Key Insights Aeon (M) Bhd's estimated fair value is RM1.89 based on 2 Stage Free Cash Flow to Equity Aeon (M) Bhd's...
Investors in Aeon (M) Bhd (KLSE:AEON) have unfortunately lost 24% over the last year
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...
The Returns At Aeon (M) Bhd (KLSE:AEON) Aren't Growing
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Aeon Co. (M) Bhd.'s (KLSE:AEON) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
With its stock down 7.9% over the past three months, it is easy to disregard Aeon (M) Bhd (KLSE:AEON). However, the...
Aeon Co. (M) Bhd.'s (KLSE:AEON) largest shareholders are public companies with 52% ownership, institutions own 33%
Key Insights Significant control over Aeon (M) Bhd by public companies implies that the general public has more power...